We have developed a method for synthesis of inositol 1,2-(cyclic)-4,5-trisphosphate from inositol 1,4,5-trisphosphate using a water-soluble carbodiimide. We obtained 1-1.5 Amol of the inositol cyclic trisphosphate starting with 5 jAmol of inositol 1,4,5-trisphosphate. The cyclized product was isolated by HPLC on Partisil SAX. The identity of the cyclic product was verified by its hydrolysis to inositol 1,4,5-trisphosphate in acid and by its conversion to 1,2-(cyclic)-4-bisphosphate by a specific 5-phosphomonoesterase from platelets. We also identified the product by 31P NMR spectroscopy, which showed a peak at 17.2 ppm, characteristic of a fivemembered cyclic phosphodiester ring, and peaks at 4.1 ppm and 0.8 ppm, indicative of phosphomonoesters. This relatively simple method for producing inositol 1,2-(cyclic)-4,5-trisphosphate will facilitate studies of the physiology of this compound in signal transduction. To obtain adequate amounts of inositol 1,2-(cyclic)-4,5-trisphosphate for structure verification and for further physiological studies, we attempted to chemically convert inositol 1,4,5-trisphosphate to inositol 1,2-(cyclic)-4,5-trisphosphate. This goal has been achieved, and we describe here the synthesis and purification of inositol 1,2-(cyclic)-4,5-trisphosphate. The cyclic product was converted to inositol 1,4,5-trisphosphate by acidification and to inositol 1,2-(cyclic)-4-bisphosphate with a specific 5-phosphomonoesterase. 31P NMR spectroscopy is consistent with the conclusion that the structure of the compound is inositol 1,2-(cyclic)-4,5-trisphosphate.
The breakdown of phosphatidylinositol phosphates by phospholipase C generates a variety of messenger molecules that include several different inositol phosphates. The inositol phosphate products of phospholipase C hydrolysis of phosphatidylinositol, phosphatidylinositol 4-phosphate, and phosphatidylinositol 4,5-bisphosphate are mixtures of the corresponding inositol phosphates and 1,2-(cyclic)phosphates (1, 2) . Recent studies using intact cells stimulated by agonists also indicate that inositol 1,2-(cyclic)phosphate (3) (4) (5) (6) and inositol 1,2-(cyclic)-4,5-trisphosphate are found in vivo (7) . Inositol 1,4,5-trisphosphate has been shown to mobilize calcium ions from intracellular stores in many cell types (8) . Inositol 1,2-(cyclic)-4,5-trisphosphate also mobilizes calcium ions in permeabilized platelets (9) and 3T3 cells (10) with a potency similar to its noncyclic counterpart. Inositol cyclic and noncyclic trisphosphates induce an increase in membrane conductance when injected into Limulus ventral photoreceptors, although the cyclic trisphosphate is five times more potent than the noncyclic compound in this tissue (9) . The relative proportion of cyclic vs. noncyclic inositol phosphates formed in vivo is currently unknown. It is also uncertain whether these two compounds have similar or different functions in various systems.
Efforts to study the physiological effects and metabolism of inositol 1,2-(cyclic)-4,5-trisphosphate have been stalled by the low yields achieved by enzymatic production of the compound from phosphatidylinositol 4,5-bisphosphate. Structural characterization of inositol 1,2-(cyclic)-4,5-trisphosphate has been difficult because of the scarcity of the material and the relative chemical instability of inositol cyclic phosphates (11) .
To obtain adequate amounts of inositol 1,2-(cyclic)-4,5-trisphosphate for structure verification and for further physiological studies, we attempted to chemically convert inositol 1,4,5-trisphosphate to inositol 1,2-(cyclic)-4,5-trisphosphate. This goal has been achieved, and we describe here the synthesis and purification of inositol 1,2-(cyclic)-4,5-trisphosphate. The cyclic product was converted to inositol 1,4,5-trisphosphate by acidification and to inositol 1,2-(cyclic)-4-bisphosphate with a specific 5-phosphomonoesterase. 31P NMR spectroscopy is consistent with the conclusion that the structure of the compound is inositol 1,2-(cyclic)-4,5-trisphosphate.
MATERIALS AND METHODS
Materials. The following chemicals and reagents were obtained from the indicated suppliers: type I Folch fraction I from bovine brain, sodium m-periodate, 2-(N-morpholino)ethanesulfonic acid, and triethylamine, Sigma (before use, the triethylamine was treated by passing it through a column of activity grade I alumina); ethylene glycol, ammonium formate, lithium chloride, and Scinti Verse I, Fisher; methylamine gas in a pressurized canister, Fluka; [ The phospholipids were deacylated by a modification of the procedure described by Clarke and Dawson (13) . A tracer amount (3.5 x 106 cpm) of [2-3H]phosphatidylinositol 4,5-bisphosphate was added to the phospholipid extract, which was dried under a flow of nitrogen and redissolved in a methylamine reagent made by bubbling monomethylamine gas through a solution (40 ml) of methanol/water/1-butanol, 20 :15:5, until the volume increased to 65 ml (13) . The round-bottom flask with ground glass stopper was tightly closed, heated at 530C for 1 hr, and then cooled on ice. Cold 1-propanol (32.5 ml) was added and the solvent mixture was *To whom reprint requests should be addressed at: Division of Hematology-Oncology, Washington University School of Medicine, 660 South Euclid, St. Louis, MO 63110.
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
removed under reduced pressure. The residue was redissolved in 20 ml of water and 24 ml of 1-butanol/light petroleum ether (bp, 40-600C)/ethyl formate, 20:4:1. After extraction, the aqueous phase containing deacylated phospholipids was washed with 15 ml of the same mixture and stored at -40C.
Degradation of deacylated phospholipids (640 ,xmol) was done essentially as described by Brown and co-workers (14, 15) . Sodium m-periodate (205 mg, 960 tmol) was allowed to react with the deacylated phospholipids for 10 min in the dark at room temperature. The reaction was stopped by the addition of 1% ethylene glycol (1.78 ml, 320 gmol). After an additional 15 min at room temperature, 1% 1,1-dimethylhydrazine (4.86 ml, 640 4mol; pH 4.5) was added, and the reaction was allowed to proceed for 4 hr in the dark at room temperature. The reaction mixture was treated with 20 ml of slurried Dowex AG 5OW-X8 (100-200 mesh) hydrogen form and then filtered through a 1-cm bed of Celite. The eluate was combined with two 5-to 10-ml water washes and lyophilized.
The sample dissolved in water was loaded on a 2-ml column of Dowex AG 1-X8 (200-400 mesh) formate form. The column was eluted as described by Downes et al. (16) . The samples were desalted by treatment with Dowex AG 5OW-X8 (100-200 mesh) hydrogen form. The inositol trisphosphate was lyophilized and phosphate was assayed as described by Ames and Dubin (17) . Following this procedure, [17] [18] [19] [20] (19) except that a small 0.5 x 8 cm Chelex column was added in front of the precolumn. The elution scheme consisted of isocratic elution with 50 mM ammonium formate (pH 6.25) for 10 min; this was followed by a linear gradient from 50 mM to 2.7 M ammonium formate (pH 6.25) over the next 20 min, which was followed by 30 min of isocratic elution with 2.7 M ammonium formate (pH 6.25). A rate of 1 ml/min was used, and 1-ml fractions were collected and assayed for radioactivity in a Beckman liquid scintillation counter either by measuring Cerenkov The reactions were stopped by freezing, and the products were separated by HPLC on Partisil SAX as described above.
NMR Spectroscopy. 31p {1H}-NMR spectra were recorded at 121 MHz on a Varian XL 300 spectrometer equipped with a 5-mm variable temperature probe using a 10-gsec pulse width, 0.8-sec acquisition time (no delay), and continuous WALTZ-16 decoupling. Chemical shifts are reported in ppm relative to 85% H3PO4 external reference at 0.0 ppm. Samples were dissolved in 2H20 for room temperature spectra and in 40% methanol/60% 2H20 for the -20'C spectrum.
RESULTS
We attempted to cyclize inositol 1,4,5-trisphosphate using dicyclohexylcarbodiimide with various amounts of tri-nbutylamine, tert-butanol, dimethylformamide, and pyridine. These experiments either gave no reaction or multiple undesired products. Poor solubility of inositol 1,4,5-trisphosphate in the mixed solvent systems needed to dissolve dicyclohexylcarbodiimide appears to be the major problem with this choice of conditions.
In initial experiments, we found that the reaction of inositol 1,4,5-trisphosphate with the water-soluble carbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride, rapidly generated several products, none of which cochromatographed on HPLC with inositol 1,2-(cyclic)-4,5-trisphosphate. We therefore added triethylamine to suppress intermolecular reactions and to prevent further reaction of the cyclic phosphate (21) . We found that the reaction would not proceed in triethylamine until the pH was reduced to 8-9. When the pH was further lowered to 5-6, multiple undesired products were formed. Thus, we carried out the reaction at pH 8.2 at room temperature. Under these conditions, inositol 1,4,5-trisphosphate was converted to inositol 1,2-(cyclic)-4,5-trisphosphate in -25% yield with only two additional products (Fig. 1) . Incubation for longer times increased the early eluting peaks without increasing the yield of the desired product. No reaction occurred at 0°C.
The HPLC fractions containing the putative cyclic product (40-43) were pooled, desalted, and examined by 31P NMR spectroscopy. At ambient temperature in 100% 2H20, the 31p {'H}-NMR spectrum consisted of a broad (64 Hz) peak at 17.2 ppm and a second broad feature at 1 ppm. Cooling the sample to 0°C gave a spectrum with a sharper down-field signal (23 Hz) and two broad but partially resolved signals at 1.8 and 0.2 ppm. At -20°C in 40% methanol/60% 2H20, the spectrum exhibited a sharp down-field signal at 17.2 ppm and two completely resolved signals at 4.1 and 0.8 ppm (Fig. 2) . For comparison, the 31P {1H}-NMR spectra of inositol 1,2-(cyclic)phosphate and inositol 1,4,5-trisphosphate are shown in Fig. 2 .
We further established the identity of the cyclic product by acid hydrolysis and enzymatic degradation. The addition of hydrochloric acid to inositol 1,2-(cyclic)-4,5-trisphosphate hydrolyzed it to inositol 1,4,5-trisphosphate (Fig. 3) , in agreement with earlier results on the characterization of this compound (1, 9) . It is possible that the 10% ofthe sample that appears acid-resistant reflects a contaminant in our product, or it may represent inositol 2,4,5-trisphosphate, which is formed in small amounts by acid hydrolysis of the cyclic compound. of inositol 1,4,5-[32P]trisphosphate was completely converted to inositol 1,4-bisphosphate. This result is similar to the conversion achieved by using enzymatically prepared inositol 1,2-(cyclic)-4,5-trisphosphate, where 85% was converted to the cyclic bisphosphate product after exhaustive digestion (22) .
DISCUSSION
The cyclization reaction mixture using 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride contains three products (Fig. 1) . When the reaction was allowed to proceed for longer periods, the two side products increased at the expense of inositol 1,2-(cyclic)-4,5-trisphosphate, implying that they may be oligomers. We monitored the reaction by HPLC and found that the best yields and the fewest products were obtained at about 25% conversion to inositol 1,2-(cyclic)-4,5-trisphosphate. Unreacted inositol 1,4,5-trisphosphate is recoverable and can undergo reaction again.
To acquire a 31p {1H}-NMR spectrum that had three resolved signals, we cooled the sample to -20TC. Since the sample could not be run in 2H20 at this temperature, methanol was added as a cryosolvent. Apparently, some conformational flexibility creates line broadening through chemical exchange above 0C. This motion is partially frozen out at lower temperatures. Comparison of the 31p {'H}-NMR spectrum of the synthetic material with spectra of inositol 1,4,5-trisphosphate and inositol 1,2-(cyclic)phosphate (Fig.  2) shows the presence of a five-membered cyclic phosphodiester ring and two phosphomonoesters.
A 31P NMR spectrum of inositol 1,4,5-trisphosphate has been reported by Lindon et al. (23) . The spectrum in that study was run at alkaline pH, which may explain the differences in chemical shifts from our findings. The characteristic down-field position of the five-membered cyclic phosphate has been observed (24) in the 2', 3' nucleotide series and has been attributed to a change in phosphorous hybridization by the 70 reduction of the O-P--O bond angle.
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